For centuries the cannabis plant has been used for its therapeutic properties.
In 2900 BC China, it was considered a popular medicine and by 100 AD had more than a 100 medicinal uses.
Some scholars believe that there is even a mention in the Bible in Exodus as kaneh bosm (cannabis).
Cannabis extracts were first medicinally used in the 1850’s in America for the purpose of treating pain and as a muscle relaxant. Pharmaceutical regulations soon followed in individual states. In the U.S. during the early 1900’s cannabis was in many medications with some pharmaceutical companies selling cannabis extracts as an analgesic, antispasmodic and sedative. One company even marketed marijuana cigarettes for asthma treatment. By 1936 all states in the U.S. had laws regulating marijuana and companies were replacing its use with aspirin, morphine and opiates.
With the passing of the Controlled Substance Act of 1970 it placed cannabis as a Schedule 1 substance, federal classification. Making medical and recreational marijuana illegal.
The 2018 Farm Bill removed hemp, including low-THC derivatives of cannabis, like CBD products, from the CSA’s definition of marijuana. Prior to this the CSA did not differentiate between marijuana and hemp. Early clinical research was focused on drug development using THC rather than CBD.
In 2018 the FDA approved Epidiolex (a prescription CBD) for the treatment of severe forms of childhood seizures. Research interest of CBD as a drug is increasing. Since the passing of the 2018 Farm Bill the CBD industry continues to grow.